New research from Osaka Metropolitan University finds that black cumin, a common kitchen spice, can lower cholesterol, reduce ...

New research combining lab experiments and a human trial reveals that black cumin seed not only downregulates the genes that ...

Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, announced today ...

Ill-health in old age is not inevitable.” These are indeed powerful words from aging researcher Claire Steves, which are ...

A comprehensive narrative review published in Translational Exercise Biomedicine, (ISSN: 2942-6812), an official partner ...

Metabolic dysfunction-associated fatty liver disease (MAFLD) has emerged as a predominant chronic liver condition globally, intricately linked with ...

The top-line results from the study showed that the 3-drugs' synergistic effect has the potential as a new fixed-dose combination treatment, enhancing the effect of Bayer's top selling cancer drug, ...

A new study published in the Journal of the American Medical Association found that among individuals with peripheral artery ...

Trained immunity is reshaping our understanding of host defense by demonstrating that innate immune cells once thought to lack memory can be reprogrammed to mount heightened responses to subsequent ...

The top-line results from the study showed that the 3-drugs' synergistic effect has the potential as a new fixed-dose combination treatment, enhancing the effect ...

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic ...